Study Finds DNA Links to Ovarian Cancer

Researchers say they have found 5 areas of DNA that are linked to ovarian cancer risk. The study included 10,200 women with ovarian cancer. Their DNA was compared with that of 13,185 women who did not have the disease. Scientists found differences in 5 areas of DNA linked to ovarian cancer risk. Four were more common among women with the fastest-growing form of ovarian cancer. A blood test can show which women have these differences. The increase in risk was small, one researcher told Postmedia News. But the study helps us to know more about this type of cancer, another researcher told HealthDay News. Doctors hope that someday they will be able to predict each woman’s risk based on her DNA. The journal Nature Genetics published the study September 19.

Content restricted. Requires subscription

Bad Week for Diet Drugs at FDA

Diet drugs did not fare well in the U.S. regulatory process this week. A panel of experts voted September 16 not to recommend approval of the drug lorcaserin. They said they were concerned about tumors in rats tested with the drugs. The panel provides advice to the U.S. Food and Drug Administration (FDA). The FDA is reviewing 3 new diet drugs now. Lorcaserin had been considered the safest one. But FDA scientists questioned that in a report released before the expert panel met. They said lorcaserin produced little weight loss. They also cited side effects. Concerns include possible heart valve damage, depression and other psychiatric problems. The expert panel also voted September 14 on whether to allow an approved drug, Meridia, to stay on the market. The vote was an 8-8 tie.

Content restricted. Requires subscription